Results 211 to 220 of about 856,908 (346)
IV.—An attempt to ascertain the Fauna of Shropshire and North Wales [PDF]
T. C. Eyton
openalex +1 more source
XLII.—Additions to the shell-fauna of the Victoria Nyanza or Lake Oukéréwé [PDF]
, 1892 Edgar A. Smith
openalex +1 more source
Ubiquitination of transcription factors in cancer: unveiling therapeutic potential
Molecular Oncology, EarlyView.In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley +1 more source
High-throughput biodiversity surveying sheds new light on the brightest of insect taxa. [PDF]
Proc Biol SciIwaszkiewicz-Eggebrecht E +11 more
europepmc +1 more source
A marine early Cretaceous fauna from Stanwell (Rockhampton District)
, 1947 Frederick William Whitehouse
openalex +2 more sources
Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?
Molecular Oncology, EarlyView.Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley +1 more source
Extensive DNA Barcoding of Lepidoptera of Crete (Greece) Reveals Significant Taxonomic and Faunistic Gaps and Supports the First Comprehensive Checklist of the Island's Fauna. [PDF]
InsectsHuemer P +9 more
europepmc +1 more source
An Addition to the Chelonian Fauna of Massachusetts
, 1916 Harold L. Babcock
openalex +2 more sources
Molecular Oncology, EarlyView.Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen +12 more
wiley +1 more source